Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $550.00 at Stifel Nicolaus

Intuitive Surgical (NASDAQ:ISRG) had its price objective cut by Stifel Nicolaus from $670.00 to $550.00 in a report released on Friday morning, Marketbeat Ratings reports. They currently have a buy rating on the medical equipment provider’s stock.

Other equities research analysts also recently issued research reports about the stock. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a report on Monday, July 6th. Jefferies Financial Group lowered their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research note on Wednesday, April 22nd. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Finally, Royal Bank Of Canada decreased their price objective on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, July 13th. One analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $523.46.

Intuitive Surgical Price Performance

ISRG opened at $345.42 on Friday. Intuitive Surgical has a 12 month low of $344.55 and a 12 month high of $603.88. The stock has a market cap of $122.33 billion, a P/E ratio of 39.57, a P/E/G ratio of 3.27 and a beta of 1.46. The stock’s 50 day moving average price is $415.28 and its 200 day moving average price is $467.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 17.09% and a net margin of 28.45%.The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. During the same quarter in the previous year, the firm posted $1.81 EPS. The firm’s quarterly revenue was up 23.0% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical will post 8.57 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president directly owned 5,720 shares in the company, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 7,169 shares of company stock worth $3,059,135 over the last three months. Corporate insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors have recently modified their holdings of ISRG. Regent Peak Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 7.2% in the second quarter. Regent Peak Wealth Advisors LLC now owns 800 shares of the medical equipment provider’s stock worth $318,000 after buying an additional 54 shares during the last quarter. Hyperion Asset Management Ltd grew its stake in Intuitive Surgical by 49.8% in the 2nd quarter. Hyperion Asset Management Ltd now owns 419,329 shares of the medical equipment provider’s stock valued at $166,759,000 after buying an additional 139,422 shares during the last quarter. Northside Capital Management LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at $669,000. Annex Advisory Services LLC lifted its position in shares of Intuitive Surgical by 37.4% during the 2nd quarter. Annex Advisory Services LLC now owns 90,943 shares of the medical equipment provider’s stock worth $36,166,000 after purchasing an additional 24,750 shares during the last quarter. Finally, Tema ETFs LLC boosted its position in shares of Intuitive Surgical by 28.8% in the second quarter. Tema ETFs LLC now owns 9,704 shares of the medical equipment provider’s stock valued at $3,859,000 after acquiring an additional 2,170 shares during the period. Institutional investors own 83.64% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported stronger-than-expected Q2 revenue and earnings, helped by solid demand for its da Vinci robotic surgery systems and continued adoption of its products. Reuters article
• Positive Sentiment: The company still reported healthy procedure growth overall, with worldwide procedures rising and placements of robotic systems remaining strong, which supports the long-term investment case. Yahoo Finance article
• Neutral Sentiment: Several analysts lowered price targets after the report, but most kept bullish ratings such as overweight, buy, or outperform, suggesting Wall Street still sees meaningful upside despite the near-term pullback. Benzinga article
• Negative Sentiment: Management did not raise its forecast for procedure growth, and investors reacted badly to slower U.S. procedure growth and a cautious full-year outlook. Benzinga article
• Negative Sentiment: Reuters also noted concerns that changes to some insurance plans could reduce demand, adding to worries about slower U.S. growth and a softer near-term procedure trajectory. Reuters article

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.